UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 365

Sortiert nach

Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis

Journal of investigational allergology & clinical immunology, 2021-12, Vol.31 (6), p.528-529

2021

Volltextzugriff (PDF)

Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate‐to‐severe atopic dermatitis

British journal of dermatology (1951), 2022-02, Vol.186 (2), p.285-294

2022

Volltextzugriff (PDF)

Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances

Journal of the European Academy of Dermatology and Venereology, 2022-10, Vol.36 (10), p.1820-1825

2022

Volltextzugriff (PDF)

Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study

Journal of the European Academy of Dermatology and Venereology, 2021-07, Vol.35 (7), p.1562-1568

2021

Volltextzugriff (PDF)

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Clinical infectious diseases, 2009-11, Vol.49 (9), p.1441-1449

2009

Volltextzugriff (PDF)

Acquired resistance to echinocandins in Candida albicans: case report and review

Journal of antimicrobial chemotherapy, 2007-06, Vol.59 (6), p.1076-1083

2007

Volltextzugriff (PDF)

Most associations of early‐life environmental exposures and genetic risk factors poorly differentiate between eczema phenotypes: the Generation R Study

British journal of dermatology (1951), 2019-12, Vol.181 (6), p.1190-1197

2019

Volltextzugriff (PDF)

A novel image processing workflow for the in vivo quantification of skin microvasculature using dynamic optical coherence tomography

Skin research and technology, 2018-08, Vol.24 (3), p.396-406

2018

Volltextzugriff (PDF)

湿疹表型的环境和遗传风险因素

British journal of dermatology (1951), 2019-12, Vol.181 (6), p.e167-e167

2019

Volltextzugriff (PDF)

Environmental and genetic risk factors of eczema phenotypes

British journal of dermatology (1951), 2019-12, Vol.181 (6), p.e155-e155

2019

Volltextzugriff (PDF)

Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy

HIV medicine, 2008-10, Vol.9 (9), p.765-770

2008

Volltextzugriff (PDF)

Evolution and duration of nodules in severe nodular acne on the back: results from a four‐week non‐interventional, prospective study

Journal of the European Academy of Dermatology and Venereology, 2019-03, Vol.33 (3), p.601-607

2019

Volltextzugriff (PDF)

The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area

British journal of cancer, 2005-10, Vol.93 (8), p.909-914

2005

Volltextzugriff (PDF)

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Antimicrobial Agents and Chemotherapy, 2010-02, Vol.54 (2), p.614-619

2010

Volltextzugriff (PDF)

Évolution naturelle des nodules dans l’acné nodulaire sévère du dos : résultats d’une étude prospective de 4 semaines

Annales de dermatologie et de vénéréologie, 2017-12, Vol.144 (12), p.S214-S214

2017

Volltextzugriff (PDF)

Étude de phase 2b sur némolizumab chez des patients adultes présentant une dermatite atopique modérée à sévère associée à un prurit sévère

Annales de dermatologie et de vénéréologie, 2019-12, Vol.146 (12), p.A109-A109

2019

Volltextzugriff (PDF)

La cerise dans le labo: Des femmes de sciences inspirées et inspirantes

Le Moine, Lucie

1, 2023

Volltextzugriff (PDF)

LB1670 Activation of pro-fibrotic processes downstream of IL-31RA signaling distinguishes prurigo nodularis from atopic dermatitis

Journal of investigative dermatology, 2023-09, Vol.143 (9), p.B9

2023

Volltextzugriff (PDF)

Dynamics of HIV-1 DNA level in highly antiretroviral-experienced patients receiving raltegravir-based therapy

European journal of clinical microbiology & infectious diseases, 2012-02, Vol.31 (2), p.129-133

2012

Volltextzugriff (PDF)

Efavirenz replacement by immediate full‐dose nevirapine is safe in HIV‐1‐infected patients in Cambodia

HIV medicine, 2008-08, Vol.9 (7), p.514-518

2008

Volltextzugriff (PDF)

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy

AIDS (London), 2008-06, Vol.22 (10), p.1203-1211, Article 1203

2008

Volltextzugriff (PDF)

Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis

The New England journal of medicine, 2023-10, Vol.389 (17), p.1579-1589

2023

Volltextzugriff (PDF)

Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis\A Reply to "Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis"

Journal of investigational allergology & clinical immunology, 2021-01, Vol.31 (6), p.528

2021

Volltextzugriff (PDF)

Knowledge of oral drug treatment in immunocompromised patients on hospital discharge

Swiss medical weekly, 2011, Vol.141, p.w13204

2011

Volltextzugriff (PDF)

314 Mass spectrometry-based plasma proteomics analysis reveals IL-31 inhibition modulates cutaneous and systemic inflammation in prurigo nodularis

Journal of investigative dermatology, 2022-08, Vol.142 (8), p.S54

2022

Volltextzugriff (PDF)

1 – 25 von 365

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(274)
Mit Volltextzugriff
(318)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(122)
Humans
(121)
Life Sciences & Biomedicine
(100)
Male
(82)
Adult
(75)
Female
(71)
Biological And Medical Sciences
(66)
Medical Sciences
(65)
Infectious Diseases
(63)
Middle Aged
(58)
Hiv Infections - Drug Therapy
(52)
Aids/hiv
(40)
Human Immunodeficiency Virus
(39)
Human Viral Diseases
(38)
Immunology
(38)
Viral Diseases
(38)
Virology
(38)
Pharmacology. Drug Treatments
(35)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(32)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(32)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis

Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate‐to‐severe atopic dermatitis

Nemolizumab efficacy in prurigo nodularis: onset of action on itch and sleep disturbances

Nemolizumab is associated with a rapid improvement in atopic dermatitis signs and symptoms: subpopulation (EASI ≥ 16) analysis of randomized phase 2B study

High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS 139 TRIO Trial

Acquired resistance to echinocandins in Candida albicans: case report and review

Most associations of early‐life environmental exposures and genetic risk factors poorly differentiate between eczema phenotypes: the Generation R Study

A novel image processing workflow for the in vivo quantification of skin microvasculature using dynamic optical coherence tomography

湿疹表型的环境和遗传风险因素

Environmental and genetic risk factors of eczema phenotypes

Drug resistance profiles for the HIV integrase gene in patients failing raltegravir salvage therapy

Evolution and duration of nodules in severe nodular acne on the back: results from a four‐week non‐interventional, prospective study

The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area

Influence of Alpha-1 Glycoprotein Acid Concentrations and Variants on Atazanavir Pharmacokinetics in HIV-Infected Patients Included in the ANRS 107 Trial

Évolution naturelle des nodules dans l’acné nodulaire sévère du dos : résultats d’une étude prospective de 4 semaines

Étude de phase 2b sur némolizumab chez des patients adultes présentant une dermatite atopique modérée à sévère associée à un prurit sévère

La cerise dans le labo: Des femmes de sciences inspirées et inspirantes

LB1670 Activation of pro-fibrotic processes downstream of IL-31RA signaling distinguishes prurigo nodularis from atopic dermatitis

Dynamics of HIV-1 DNA level in highly antiretroviral-experienced patients receiving raltegravir-based therapy

Efavirenz replacement by immediate full‐dose nevirapine is safe in HIV‐1‐infected patients in Cambodia

Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy

Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis

Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis\A Reply to "Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis"

Knowledge of oral drug treatment in immunocompromised patients on hospital discharge

314 Mass spectrometry-based plasma proteomics analysis reveals IL-31 inhibition modulates cutaneous and systemic inflammation in prurigo nodularis

Suchergebnisse filtern